home All News open_in_new Full Article

Švajcarski farmaceutski div kupuje američku biotehnološku kompaniju za 12 milijardi dolara

Švajcarski farmaceutski div Novartis objavio je da je postigao sporazum o kupovini američke biotehnološke kompanije Avidity Biosciences za otprilike 12 milijardi dolara (10.31 milijardi eura). 


today 8 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 3707737228
Add Watch Country

arrow_drop_down